Takeda's $2.4B Actos Deal Ends 5th Circ. Appeal
The Fifth Circuit on Tuesday dismissed without prejudice an appeal by Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. over a $36.8 million award to class action plaintiffs claiming that...To view the full article, register now.
Already a subscriber? Click here to view full article